News
News
Medtronic to acquire the French implant tech company Medicrea
Medtronic plc , a global leader in medical technology, and Medicrea, a pioneer in the transformation of spinal surgery through artificial intelligence, predictive modeling and patient specific implants, announced that they have entered into a tender offer agreement for...
News
Paige Receives FDA Clearance for the FullFocus Viewer for Digital Pathology
Paige, a specialist in computational pathology, has announced it has received FDA 510(k) clearance for the FullFocus™ viewer for primary diagnosis of digital pathology slides. While the FullFocus viewer intuitively allows pathologists to view and navigate images from all...
News
Dedalus Acquires DXC’s Provider Healthcare Business
DXC Technology announced a definitive agreement to sell DXC’s healthcare software provider business to privately held Dedalus Group for $525 million in cash.
The agreement brings together DXC’s software business for healthcare providers with Dedalus, a leading European healthcare and...
News
ndd’s new inline filters offer additional protection against COVID-19 during lung function tests
ndd Medical Technologies (ndd), a leading provider of diagnostic technology enabling healthcare professionals the early detection of COPD and other chronic lung diseases, has introduced new single patient-use, inline filters for its lung function testing devices, in response to...
News
ViruShield launches the ViruShield Ghost as new innovative solution to cloth mask
ViruShield, a California-based company that creates groundbreaking products to mitigate against the emergence of COVID-19 through inventive design and state-of-the-art technology, announces the launch of the ViruShield Ghost. The patent pending Ghost is a transparent, strapless, and reusable respiratory...
News
UK government to launch free finger-prick Covid-19 tests
The UK government is set to launch free Covid-19 antibody tests, which deliver results in 20 minutes, following finger-prick after successful secret trials.
The test was found to be 98.6% accurate in secret human trials. It has been developed by...
News
Bioventus Makes $15 Million Equity Investment in CartiHeal to Acquire Company Upon Milestone Achievements
CartiHeal, developer of the proprietary Agili -C implant for the treatment of joint surface lesions in traumatic and osteoarthritic joints, has secured an additional $15 million equity investment from Bioventus, a global leader in orthobiologics. The investment follows the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
